My Account Log in

4 options

The $800 million pill : the truth behind the cost of new drugs / Merrill Goozner.

De Gruyter University of California Press Backlist eBook-Package 2000-2013 Available online

View online

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central Academic Complete Available online

View online

Ebook Central College Complete Available online

View online
Format:
Book
Author/Creator:
Goozner, Merrill, 1950-
Language:
English
Subjects (All):
Prescription pricing.
Drugs--Prices.
Drugs.
Pharmaceutical industry.
Consumer education.
Physical Description:
1 online resource (304 pages)
Edition:
1st ed.
Other Title:
Eight hundred million dollar pill
Place of Publication:
Berkeley : University of California Press, 2004.
Language Note:
English
Summary:
Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The
Contents:
Front matter
Contents
Introduction
PART ONE. BIOHYPE
PART TWO. DIRECTED RESEARCH
PART THREE. BIG PHARMA
Notes
Bibliography
Acknowledgments
Index
Notes:
Description based upon print version of record.
Includes bibliographical references and index.
ISBN:
9786612358241
9781282358249
1282358243
9780520939288
052093928X
9781597344500
1597344508
OCLC:
808037855

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account